Recall: Brimonidine
Mar. 2023Pharmacy Updates
Apotex Corp. is voluntarily recalling six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15%. The drug is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. This recall is due to cracks that have developed in some of the Brimonidine tartrate ophthalmic solution bottles’ caps. Read the full text of the Brimonidine recall.
Recent Announcements
CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives
Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.Oct. 2026Education/Webinars
CME Webinar: Navigating Grief Conversations
Please join us for a live, CME-accredited webinar on Thursday, Nov. 12, 2026, that will enhance your confidence and effectiveness in supporting patients dealing with loss & grief.Oct. 2026Education/Webinars
Provider OnLine Login Changes for UPMC Employees and UPMC Children’s Hospital of Pittsburgh Employees
UPMC employees and UPMC Children’s Hospital of Pittsburgh employees will now use their email address to access Provider OnLine.Oct. 2026Important Notices